Search

Search Constraints

You searched for: Author/Creator Facon, Thierry

Search Results

61. Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk. Issue 9 (5th July 2021)

62. Subgroup analysis of ICARIA‐MM study in relapsed/refractory multiple myeloma patients with high‐risk cytogenetics. (25th May 2021)

63. Targeting BCL‐2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma. Issue 4 (19th January 2021)

65. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group. Issue 3 (March 2021)